Pharmapolis – The pharmaceutical community capital - pharmapolis.net

Pharmapolis – The pharmaceutical community capital - pharmapolis.net

DNA Microarrays: Inside and Out

Microfluidics and Lab-on-a-chip analysis

Hot-Melt Extrusion: Novelty In Pharmaceutical Manufacturing

ICP Mass Spectrometry

HPLC Method Development for Proteins and Polypeptides

Core-shell particle technology UHPLC performance on HPLC systems?

General Protein Stabiity and Stability Study

Amylin Pharma Under Scope Before Sale

Freedom Cervical Disc from AxioMed Approved

Thermo Fisher’s New Chromatography Patent

PerkinElmer Acquires Labtronics Inc

Researchers Found the Master Gene for Obesity and Diabetes

Teva and CureTech Announce Positive Phase II Data from CT-011

FDA Approves Merck’s VICTRELIS Hepatitis C Virus Protease Inhibitor

Sanofi and Glenmark Pharm. Agreed on Novel Monoclonal Antibody for Crohn’s Disease

Pfizer To Present New Research To Targeting Cancer At 2011 ASCO

Alpha MOS Launches its New Heracles Gas Chromatograph

AgenoLAB to use Roches RTCA Cardio Instrument

EMA Acknowledges Clinuvel’s Novel Drug Filing in Europe in 2011

Corporate News

Amount of short articles: 012345

Amount of articles links: 012345678910

You can order sections with dragging on list bellow:

Financials

Positive Prognosis for the US and Europe Launch of

Decision Resources, one of the worlds leading research and advisory firms for pharmaceutical and healthcare is

Wednesday, 11 May 2011

Acquisitions

Amylin Pharmaceuticals Inc. (AMLN) has lured suitors such as Pfizer Inc. (PFE), AstraZeneca Plc (AZN) an

Tuesday, 15 May 2012

Collaborations

Microfluidics Specialist Dolomite Signs Collaborat

The Dolomite Centre Ltd has signed a collaboration agreement with Sphere Fluidics, a leading company in

Tuesday, 10 May 2011

Pharmaceutical and Biotech Advances

Advances

AxioMed Spine Corporation announces the receipt of CE Mark approval for its Freedom Cervical Disc, an

Vaccines and Biotech

Teva and CureTech Announce Positive Phase II Data

Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries an

Tuesday, 17 May 2011

New Products and Formulations

Pfizer To Present New Research To Targeting Cancer

Pfizer Inc. will present more than 30 abstracts, including data from investigational compounds, axitinib,1 crizotinib,2 an

Monday, 16 May 2011

Equipment

pharmapolis.net – Separation and Chromatography

Thermo Fisher Scientific is pleased to announce a new patent for Two-Dimensional Ion Chromatography (2D-IC): US

Spectroscopy Equipment

Agilent Technologies Introduces Next-Generation Ca

Agilent Technologies Inc. introduced a new Cary 60 UV-Vis, the leader in xenon flash lamp te

General Lab Equipment

AgenoLAB, the Stuttgart-based service provider, is the first company in Germany to expand its service of

Thursday, 12 May 2011

Regulatory News

Drug Agencies News

Bristol-Myers Squibb Recalls Coumadin Crystalline

Bristol-Myers Squibb initiated a voluntary recall of one lot of 1,000-count bottles of Coumadin (warfarin so

Wednesday, 4 May 2011

Standards and Compendia

pharmapolis.net – Virtify PIM Enterprise Simplifies EMA’s Labeling

Virtify Inc. is developing a new software product Virtify PIM Enterprise, which will be part of the V

Sunday, 19 September 2010

Drug Approvals and Marketing

FDA Approves Merck’s VICTRELIS Hepatitis C Virus P

Merck announced today that the U.S. Food and Drug Administration (FDA) has approved VICTRELISTM (boceprevir), th

Drugs and Healthcare

Healthcare

FDA Clears iPhone and iPad Radiology Application

A new mobile radiology application cleared today by the U.S. Food and Drug Administration will al

Monday, 7 February 2011

Drugs and Therapy

Ranbaxy Launches Olanzapine Tablets

Ranbaxy Laboratories Limited announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa. Ra

Tuesday, 26 April 2011

Pfizer Recalls Drug Acquired with King Deal

Recently Pfizer has recalled an opioid painkiller named Embeda, obtained with the acquisition of King Ph

Thursday, 17 March 2011

Pharmapolis Forum

Join the Pharmapolis Forum and become a member of our growing community of professionals and scientists.

By registering to Pharmapolis.net you will be able to actively participate in the ongoing discussions, ask questions, post opinions, publish voting polls etc.

Regulatory Corner

Company Directory

Which of the listed social media provide you with valid pharma news?

Latest in the Forum

Featured Articles

The novel trend in drug development is…

What are core-shell or fused-core particles? The co…

Introduction Proteins represent a heterogeneous class of biologic…

Introduction ICP-MS which stands for inductively coupled plasma m…

Introduction Microarray-based genomic technologies have revolutionized the ge…

Coming Events

PositiveID to Buy MicroFluidic Systems for Approximately $8.2 M

Positive Prognosis for the US and Europe Launch of Regeneron

Dionex Launches New IonPac CS19 Cation-Exchange Column

PerkinElmer, Inc., a global leader focused on the health and safety of people and the en

Researchers Found the Master Gene for Obesity an

A team of researchers, led by King’s College London and the University of Oxford, have fo

Alpha MOS Launches its New Heracles Gas Chromatogr

A new ultra fast Gas Chromatography system has been developed for lab analysis in which ra

How do you normally find out about recalls of pharma products?